Park Medi World Ltd (PARKHOSPS) — shareholding pattern, promoter holding, financials and share price
About Park Medi World Ltd (PARKHOSPS)
Park Medi World Ltd operates in the Hospital industry, within the Healthcare sector. It trades on the NSE as PARKHOSPS and on the BSE under scrip code 544645. Its ISIN is INE119201023.
Park Medi World engaged in the business of, inter alia, establishing, maintaining and running hospitals, nursing homes, clinics, dispensaries, maternity homes, child welfare, family planning etc.(Source : 202503 Annual Report Page No:320)
Park Medi World Limited operates one of the largest private hospital chains in North India, offering over 30 medical specialties and cutting-edge healthcare services across 14 NABH-accredited hospitals.
In 2025, they reported robust financial performance, including a 17% revenue increase, signifying effective growth strategy execution and solid operational capabilities.
Listed peers in Hospital: Dr Agarwals Health Care Ltd, Rainbow Childrens Medicare Ltd, Healthcare Global Enterprises Ltd, Jupiter Life Line Hospitals Ltd, Yatharth Hospital & Trauma Care Services Ltd, Kovai Medical Center & Hospital Ltd.
Valuation & Returns
10 Jul 2026At ₹284.8 a share on 10 Jul 2026, Park Medi World Ltd (PARKHOSPS) was valued at a price-to-earnings ratio of 47.22x against an industry P/E of 61.73x and a price-to-book of 11.5x on a book value of ₹24.76 per share as of Mar 2025. Solomo computes return on equity of 24.36% and return on capital employed of 22.72% from filed results. Earnings ratios use consolidated results for the twelve months Mar 2025 to Mar 2026.
- P/E
- 47.22x
- Industry P/E
- 61.73x
- P/B
- 11.5x
- EPS (TTM)
- ₹6.03
- Book value / share
- ₹24.76
- ROE
- 24.36%
- ROCE
- 22.72%
- ROA
- 12.21%
- Debt / equity
- 0.64x
- Dividend yield
- 0%
- EBITDA margin
- 28.31%
- 52-week range
- ₹138.15 – ₹305.25
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Park Medi World Ltd (PARKHOSPS) reported revenue of ₹1,679 crore, net profit of ₹274 crore and earnings per share of ₹5.98. That compares with revenue of ₹1,394 crore and net profit of ₹213 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹460 crore and net profit ₹77 crore (consolidated).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 1,084 | 1,255 | 1,231 | 1,394 | 1,679 |
| Net profit (₹ cr) | 199 | 228 | 152 | 213 | 274 |
| EPS (₹) | 11.76 | 14.29 | 9.98 | 5.34 | 5.98 |
| Measure | 3Y | 1Y |
|---|---|---|
| Sales growth | 8.72% | 13.20% |
| Profit growth | 2.26% | 40.27% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 82.89% of Park Medi World Ltd (PARKHOSPS) (unchanged from the previous quarter), foreign institutional investors (FII) hold 0.82% and domestic institutional investors (DII) hold 8.95%. Market capitalisation was ₹12,301 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Dec 2025.
Largest disclosed public shareholders in Jun 2026: KOTAK CONTRA FUND 5.11%, CARNELIAN BHARAT AMRITKAAL FUND 1.04%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 82.89% | - | 0.82% | 8.95% | 17.11% |
| Mar 2026 | 82.89% | - | 0.86% | 9.25% | 17.11% |
| Dec 2025 | 82.89% | - | 1.28% | 8.78% | 17.11% |